(Q27655439)

10

0 references

Giovanni Di Maira

Giovanni di Maira

6

0 references

Marco Mazzorana

Marco Mazzorana

2

0 references

Alessandra Gianoncelli

Alessandra Gianoncelli

7

0 references

Giorgio Cozza

Giorgio Cozza

1

0 references

Mario A Pagano

Mario A Pagano

8

0 references

Lorenzo A Pinna

Lorenzo A Pinna

15

0 references

Stefano Moro

Stefano Moro

13

0 references

Stefania Sarno

Stefania Sarno

9

0 references

author name string

Elena Papinutto

3

0 references

Jenny Bain

4

0 references

Matthew Elliott

5

0 references

Roberto Battistutta

11

0 references

Flavio Meggio

12

0 references

Giuseppe Zagotto

The interaction of CK2α and CK2β, the subunits of protein kinase CK2, requires CK2β in a preformed conformation and is enthalpically driven

14

0 references

language of work or name

English

0 references

publication date

15 July 2009

0 references

published in

Biochemical Journal

0 references

volume

421

0 references

issue

3

0 references

page(s)

387-95

0 references

cites work

1 reference

Evolved to be active: sulfate ions define substrate recognition sites of CK2alpha and emphasise its exceptional role within the CMGC family of eukaryotic protein kinases

21 April 2017

1 reference

Structure-based design, synthesis, and study of pyrazolo[1,5-a][1,3,5]triazine derivatives as potent inhibitors of protein kinase CK2

21 April 2017

1 reference

Structure-based design and synthesis of novel macrocyclic pyrazolo[1,5-a] [1,3,5]triazine compounds as potent inhibitors of protein kinase CK2 and their anticancer activities

21 April 2017

1 reference

Biochemical and three-dimensional-structural study of the specific inhibition of protein kinase CK2 by [5-oxo-5,6-dihydroindolo-(1,2-a)quinazolin-7-yl]acetic acid (IQA)

21 April 2017

1 reference

The selectivity of protein kinase inhibitors: a further update

21 April 2017

1 reference

Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction

21 April 2017

1 reference

The CCP4 suite: programs for protein crystallography

21 April 2017

1 reference

Refinement of macromolecular structures by the maximum-likelihood method

21 April 2017

1 reference

Coot: model-building tools for molecular graphics

21 April 2017

1 reference

SFCHECK: a unified set of procedures for evaluating the quality of macromolecular structure-factor data and their agreement with the atomic model

21 April 2017

1 reference

PROCHECK: a program to check the stereochemical quality of protein structures

21 April 2017

1 reference

The ATP-binding site of protein kinase CK2 holds a positive electrostatic area and conserved water molecules

21 April 2017

1 reference

The catalytic subunit of human protein kinase CK2 structurally deviates from its maize homologue in complex with the nucleotide competitive inhibitor emodin

21 April 2017

1 reference

The replacement of ATP by the competitive inhibitor emodin induces conformational modifications in the catalytic site of protein kinase CK2

21 April 2017

1 reference

21 April 2017

The Protein Data Bank

1 reference

Gaussian docking functions

21 April 2017

1 reference

Development and validation of a genetic algorithm for flexible docking

21 April 2017

1 reference

One-thousand-and-one substrates of protein kinase CK2?

21 April 2017

1 reference

https://api.crossref.org/works/10.1042%2FBJ20090069

Protein kinase CK2: a challenge to canons

21 April 2017

1 reference

https://api.crossref.org/works/10.1042%2FBJ20090069

Protein kinase CK2: structure, regulation and role in cellular decisions of life and death

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20090069

Protein kinase CK2--a key suppressor of apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20090069

Protein kinase CK2 in human diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20090069

Optimization of protein kinase CK2 inhibitors derived from 4,5,6,7-tetrabromobenzimidazole

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20090069

Inhibition of protein kinase CK2 by condensed polyphenolic derivatives. An in vitro and in vivo study

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20090069

Identification of polyoxometalates as nanomolar noncompetitive inhibitors of protein kinase CK2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20090069

The selectivity of inhibitors of protein kinase CK2: an update

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20090069

Selective inhibition of the growth of ras-transformed human bronchial epithelial cells by emodin, a protein-tyrosine kinase inhibitor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20090069

Tyrosine kinase inhibitors, emodin and its derivative repress HER-2/neu-induced cellular transformation and metastasis-associated properties.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20090069

Protein kinase CK2 phosphorylates and upregulates Akt/PKB.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20090069

Protein kinase CK2 inhibitor 4,5,6,7-tetrabromobenzotriazole (TBB) induces apoptosis and caspase-dependent degradation of haematopoietic lineage cell-specific protein 1 (HS1) in Jurkat cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20090069

Identification of novel protein kinase CK1 delta (CK1delta) inhibitors through structure-based virtual screening

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20090069

Toward the rational design of protein kinase casein kinase-2 inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20090069

Selectivity of 4,5,6,7-tetrabromobenzotriazole, an ATP site-directed inhibitor of protein kinase CK2 ('casein kinase-2').

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20090069

2-Dimethylamino-4,5,6,7-tetrabromo-1H-benzimidazole: a novel powerful and selective inhibitor of protein kinase CK2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20090069

Further development and validation of empirical scoring functions for structure-based binding affinity prediction

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20090069

Tetrabromocinnamic Acid (TBCA) and Related Compounds Represent a New Class of Specific Protein Kinase CK2 Inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20090069

Expression, purification and crystallization of the catalytic subunit of protein kinase CK2 from Zea mays

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20090069

Identification of Ellagic Acid as Potent Inhibitor of Protein Kinase CK2: A Successful Example of a Virtual Screening Application

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20090069

Protein Kinase CK2 Mutants Defective in Substrate Recognition

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20090069